Cargando…
SGLT2 inhibitors in the treatment of type 2 cardiorenal syndrome: Focus on renal tubules
The pathogenesis of type 2 cardiorenal syndrome (CRS) is mostly associated with reduced cardiac output, increased central venous pressure (CVP), activation of the renin-angiotensin-aldosterone system (RAAS), inflammation, and oxidative stress. As a drug to treat diabetes, sodium-glucose transporter...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479647/ https://www.ncbi.nlm.nih.gov/pubmed/37674989 http://dx.doi.org/10.3389/fneph.2022.1109321 |